The forgotten male cancers: 2 Nov Public Lecture by Professor T. Clark Gamblin

Professor T.Clark Gamblin, visiting Fulbright Scholar, is giving
a public lecture 2 Nov 2017 at the Alfred Medical Research and
Education (AMREP) centre. RSVP here for catering purposes

You are invited to a public lecture by an internationally renowned surgeon, Professor T. Clark Gamblin, on the forgotten but lethal male cancers, including those of the pancreas, liver and oesophagus.

Details

• Date: Thursday, 2 November 2017
• Time: 5.30 pm drinks and canapes for 6.00 pm start. Lecture followed by Q&A session.
• Venue: AMREP Lecture Theatre, adjacent to the Baker Institute at 75 Commercial Road, Melbourne 3004, 200 metres east of the main Alfred Hospital entrance. See map.
• Cost: Free
• RSVP: CLICK HERE. Please RSVP by Monday 30 October 2017 for catering purposes
• Enquiries: Jacki.Sievers@monash.edu ph +61 3 9903 0190 or Daphne.Vogiagis@monash.edu ph +61 3 9903 30611

Abstract

Most men are aware of the risk of prostate cancer and the need for early detection and treatment.  Prostate cancer is the most commonly diagnosed cancer in Australian men, but fortunately, 95% of men diagnosed with it can expect to survive at least 5 years.

There are other cancers that predominantly affect men.  These are the less known or forgotten male cancers.  They include cancers of the pancreas, liver and oesophagus. All of these cancers affect nearly four times as many men as women. Once diagnosed only 7.7% with pancreatic cancer, 17.8% with liver cancer and 20.1% with oesophageal cancer can expect to survive more than 5 years.
 
Alarmingly, each year the number of people diagnosed with these cancers increases.  They are amongst the most rapidly increasing cancers in our community.  This makes it imperative that we find ways to improve the outlook for patients diagnosed with these cancers. This may be achieved by improving treatments and surgical techniques as well as by raising public awareness of the early warning signs that one of these cancers may be developing.  If we can catch these cancers early – we have more hope of providing a cure. 

 

More about our speaker

Professor T. Clark Gamblin MD, MS, MBA is the Chief of Surgical Oncology, Medical College of Wisconsin, Milwaukee.  He is an internationally renowned surgeon specialising in cancers of the liver and pancreas.  His clinical and research interests focus on improving treatment options and outcomes for patients affected by these cancers.  Professor Gamblin is a Fulbright Scholar who is visiting Australia on the Fulbright Specialist Program.  This long established program is designed to strengthen collaboration between US and foreign host institutions.  We are delighted to be hosting him at The Alfred.  Whilst here, Prof Gamblin will be promoting a public lecture focusing on ways of improving outcomes of these forgotten, but lethal, cancers that predominantly affect men. 

Key Facts

In 2017 it is likely that liver, oesophageal and pancreatic cancer will be diagnosed in 4,462 Australian men.

-->Liver Cancer


-->Oesophageal Cancer


-->Pancreatic Cancer



These cancers have high death rates with only small proportions of patients diagnosed expected to live 5 years:



-->Liver Cancer

-->Oesophageal Cancer

-->Pancreatic Cancer

The Department of Surgery

To host Professor Gamblin's visit, Mr Charles Pilgrim applied to the Fulbright Specialist Program with the assistance of Dr Daphne Vogiagis, both of whom are from Department of Surgery, Monash at The Alfred hospital.

Professor Gamblin will stay in Australia for three weeks in October and November. He will present at various events held at Monash University, The Alfred Hospital and elsewhere.  Based on his research and surgical experience he will provide valuable insights to registrars, trainees, surgeons, clinicians and researchers.